Sugi Predict

Sugi Predict / Targets / DCUN1D1

DCUN1D1

DCN1-like protein 1 · Q96GG9 · DCUN1D1 on Sugi Atlas →

30,505 patent compounds predicted against DCUN1D1, 12,796 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL548245 SCHEMBL548245 0.58 19/20
SCHEMBL548246 SCHEMBL548246 0.55 19/20
SCHEMBL548234 SCHEMBL548234 0.72 18/20
SCHEMBL549026 SCHEMBL549026 0.64 18/20
SCHEMBL549106 SCHEMBL549106 0.60 17/20
SCHEMBL341274 SCHEMBL341274 0.65 16/20
SCHEMBL342885 SCHEMBL342885 0.53 15/20
SCHEMBL340688 SCHEMBL340688 0.52 15/20
SCHEMBL653373 SCHEMBL653373 0.36 14/20
SCHEMBL653374 SCHEMBL653374 0.36 14/20
SCHEMBL926328 SCHEMBL926328 0.53 12/20
SCHEMBL1000516 SCHEMBL1000516 0.51 12/20
SCHEMBL1146908 SCHEMBL1146908 0.60 11/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL1326806) 0.56 11/20
SCHEMBL656386 SCHEMBL656386 0.36 11/20
SCHEMBL656387 SCHEMBL656387 0.36 11/20
SCHEMBL654521 SCHEMBL654521 0.33 11/20
SCHEMBL656375 SCHEMBL656375 0.34 10/20
SCHEMBL656376 SCHEMBL656376 0.34 10/20
Pencycuron Pencycuron (SCHEMBL22525) 0.60 9/20

Clinical trials — most relevant to DCUN1D1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer PHASE2UNKNOWN
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100 PHASE1/PHASE2COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Novel Peptide Vaccination for Patients With Advanced Bladder Cancer PHASE1COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer PHASE1COMPLETED
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study nanRECRUITING
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies nanRECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
PCD New Gene Discovery nanCOMPLETED
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
New Signaling Pathway Targeting Systemic Lupus Erythematosus nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Child Development and Genetic Biomarkers(II): Gene Verification and Data Integration nanUNKNOWN
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Study of a Candidate Gene Involved in Goldenhar Syndrome. nanCOMPLETED
The Genetics of Chiari Type I Malformation nanCOMPLETED
Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders nanCOMPLETED
Genetic Analyses of Nonsyndromic and Syndromic Deafness in Pakistan nanENROLLING_BY_INVITATION
Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. nanCOMPLETED
Genetic Study of Patients With Primary Ciliary Dyskinesia nanCOMPLETED
Neurogenetics Patient Registry nanRECRUITING
Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia nanRECRUITING
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Markers and Mechanisms of Macrovascular Disease in IDDM nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a DCUN1D1 binder may also engage these)

ProteinNameSimilarity
Q5ZKU1 — 1.000 Q5ZKU1 →
Q9QZ73 — 1.000 Q9QZ73 →
Q8BZJ7 — 0.994 Q8BZJ7 →
DCUN1D2 DCN1-like protein 2 0.976 landscape →
DCUN1D5 DCN1-like protein 5 0.958 landscape →
Q1RMX9 — 0.957 Q1RMX9 →
Q5RDF9 — 0.953 Q5RDF9 →
Q3ZBD9 — 0.945 Q3ZBD9 →
Q5R664 — 0.944 Q5R664 →
Q4R4I8 — 0.944 Q4R4I8 →
Q9CXV9 — 0.943 Q9CXV9 →
Q68FK8 — 0.942 Q68FK8 →
Q61166 — 0.942 Q61166 →
Q5PPL2 — 0.941 Q5PPL2 →
COPB2 Coatomer subunit beta' 0.941 landscape →
NXF1 Nuclear RNA export factor 1 0.941 landscape →
O35142 — 0.940 O35142 →
Q60605 — 0.940 Q60605 →
Q5R844 — 0.940 Q5R844 →
Q66H80 — 0.940 Q66H80 →
Q6V291 — 0.940 Q6V291 →
Q3MHE4 — 0.939 Q3MHE4 →
B1H2N3 — 0.939 B1H2N3 →
Q5ZLC7 — 0.939 Q5ZLC7 →
P60662 — 0.939 P60662 →
P17426 — 0.938 P17426 →
AP2A2 AP-2 complex subunit alpha-2 0.937 landscape →
P43247 — 0.937 P43247 →
P54275 — 0.937 P54275 →
AP2A1 AP-2 complex subunit alpha-1 0.937 landscape →